3 Followers on Owler
Antag is a biotechnology company that focuses on novel treatments for dietary-related metabolic diseases... Read more
OverviewFundingNews & Insights
Antag is a biotechnology company that focuses on novel treatments for dietary-related metabolic diseases... Read more
Antag Therapeutics CEO: Joerg Moeller

CEO

Joerg Moeller

CEO Approval Rating

- -/100

2017

PrivateIndependent Company

Pharmaceuticals & Biotechnology
PharmaceuticalsMedical Research & Laboratories
28348731 NAICS listing

Est. Annual Revenue
$100K-5.0M
Agree?
Est. Employees
1-25
Agree?
Funding
$87M

News

Leadership Change
Jan 08, 2025
FinanzNachrichten
Joerg Moeller is now CEO at Antag Therapeutics
Funding
Dec 05, 2024
BioSpace
Antag Therapeutics received $84M in Series A Funding

Trending Companies